This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hearing Loss
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Reducing power consumption in the cochlear implant is crucial to the development of future smaller sound processors. The commercial MP3000 sound coding strategy has been shown to be more efficient in power consumption to the standard ACE strategy. However in order to develop smaller sound processors, further battery life power savings are required. The aim of this study is to evaluate three experimental sets of MP3000 parameter sets, compared against the default ACE program. In the background for each of the four strategies, experimental noise reduction programs (SpatialNR and NR3) will also be in use. In an additional phase of the study, low stimulation rate ACE programs will also be evaluated against the default stimulation rate.

Provided treatments

  • Device: MP3000 sound coding strategy or ACE strategy with lower stimulation

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02879539. The sponsor of the trial is The Hearing Cooperative Research Centre and it is looking for 38 volunteers for the current phase.
Official trial title:
Clinical Assessment of a Low Power Strategy for Cochlear Implant Recipients